PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis

Hikaru Sasaki, Magdalena C. Zlatescu, Rebecca A. Betensky, Yasushi Ino, J. Gregory Cairncross, David N. Louis

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

Allelic loss of 10q is a common genetic event in malignant gliomas, with three 10q tumor suppressor genes, ERCC6, PTEN, and DMBT1, putatively implicated in the most common type of malignant glioma, glioblastoma. Anaplastic oligodendroglioma, another type of malignant glioma, provides a unique opportunity to study the relevance of particular genetic alterations to chemosensitivity and survival. We therefore analyzed these three genes in 72 anaplastic oligodendrogliomas. Deletion mapping demonstrated 10q loss in 14 of 67 informative cases, with the PTEN and DMBT1 regions involved in all deletions but with the ERCC6 locus spared in two cases. Seven tumors had PTEN gene alterations; two had homozygous DMBT1 deletions, but at least one reflected unmasking of a germline DMBT1 deletion. No mutations were found in ERCC6 exon 2. Chemotherapeutic response occurred in two of the seven tumors with PTEN alterations, but with unexpected short survival times. PTEN gene alterations were not associated with poor therapeutic response in multivariate analysis, but were independently predictive of poor prognosis even after multivariate adjustment for both 10q and 1p loss. In anaplastic oligodendroglioma, therefore, PTEN is a target of 10q loss, and PTEN alterations are associated with poor prognosis, even in chemosensitive cases.

Original languageEnglish
Pages (from-to)359-367
Number of pages9
JournalAmerican Journal of Pathology
Volume159
Issue number1
DOIs
Publication statusPublished - 2001 Jan 1
Externally publishedYes

Fingerprint

Oligodendroglioma
Glioma
Chromosomes
Genes
Loss of Heterozygosity
Glioblastoma
Tumor Suppressor Genes
Exons
Neoplasms
Multivariate Analysis
Mutation
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. / Sasaki, Hikaru; Zlatescu, Magdalena C.; Betensky, Rebecca A.; Ino, Yasushi; Cairncross, J. Gregory; Louis, David N.

In: American Journal of Pathology, Vol. 159, No. 1, 01.01.2001, p. 359-367.

Research output: Contribution to journalArticle

Sasaki, Hikaru ; Zlatescu, Magdalena C. ; Betensky, Rebecca A. ; Ino, Yasushi ; Cairncross, J. Gregory ; Louis, David N. / PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. In: American Journal of Pathology. 2001 ; Vol. 159, No. 1. pp. 359-367.
@article{408a2da020b548db811d5f0c5b2c01da,
title = "PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis",
abstract = "Allelic loss of 10q is a common genetic event in malignant gliomas, with three 10q tumor suppressor genes, ERCC6, PTEN, and DMBT1, putatively implicated in the most common type of malignant glioma, glioblastoma. Anaplastic oligodendroglioma, another type of malignant glioma, provides a unique opportunity to study the relevance of particular genetic alterations to chemosensitivity and survival. We therefore analyzed these three genes in 72 anaplastic oligodendrogliomas. Deletion mapping demonstrated 10q loss in 14 of 67 informative cases, with the PTEN and DMBT1 regions involved in all deletions but with the ERCC6 locus spared in two cases. Seven tumors had PTEN gene alterations; two had homozygous DMBT1 deletions, but at least one reflected unmasking of a germline DMBT1 deletion. No mutations were found in ERCC6 exon 2. Chemotherapeutic response occurred in two of the seven tumors with PTEN alterations, but with unexpected short survival times. PTEN gene alterations were not associated with poor therapeutic response in multivariate analysis, but were independently predictive of poor prognosis even after multivariate adjustment for both 10q and 1p loss. In anaplastic oligodendroglioma, therefore, PTEN is a target of 10q loss, and PTEN alterations are associated with poor prognosis, even in chemosensitive cases.",
author = "Hikaru Sasaki and Zlatescu, {Magdalena C.} and Betensky, {Rebecca A.} and Yasushi Ino and Cairncross, {J. Gregory} and Louis, {David N.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0002-9440(10)61702-6",
language = "English",
volume = "159",
pages = "359--367",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis

AU - Sasaki, Hikaru

AU - Zlatescu, Magdalena C.

AU - Betensky, Rebecca A.

AU - Ino, Yasushi

AU - Cairncross, J. Gregory

AU - Louis, David N.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Allelic loss of 10q is a common genetic event in malignant gliomas, with three 10q tumor suppressor genes, ERCC6, PTEN, and DMBT1, putatively implicated in the most common type of malignant glioma, glioblastoma. Anaplastic oligodendroglioma, another type of malignant glioma, provides a unique opportunity to study the relevance of particular genetic alterations to chemosensitivity and survival. We therefore analyzed these three genes in 72 anaplastic oligodendrogliomas. Deletion mapping demonstrated 10q loss in 14 of 67 informative cases, with the PTEN and DMBT1 regions involved in all deletions but with the ERCC6 locus spared in two cases. Seven tumors had PTEN gene alterations; two had homozygous DMBT1 deletions, but at least one reflected unmasking of a germline DMBT1 deletion. No mutations were found in ERCC6 exon 2. Chemotherapeutic response occurred in two of the seven tumors with PTEN alterations, but with unexpected short survival times. PTEN gene alterations were not associated with poor therapeutic response in multivariate analysis, but were independently predictive of poor prognosis even after multivariate adjustment for both 10q and 1p loss. In anaplastic oligodendroglioma, therefore, PTEN is a target of 10q loss, and PTEN alterations are associated with poor prognosis, even in chemosensitive cases.

AB - Allelic loss of 10q is a common genetic event in malignant gliomas, with three 10q tumor suppressor genes, ERCC6, PTEN, and DMBT1, putatively implicated in the most common type of malignant glioma, glioblastoma. Anaplastic oligodendroglioma, another type of malignant glioma, provides a unique opportunity to study the relevance of particular genetic alterations to chemosensitivity and survival. We therefore analyzed these three genes in 72 anaplastic oligodendrogliomas. Deletion mapping demonstrated 10q loss in 14 of 67 informative cases, with the PTEN and DMBT1 regions involved in all deletions but with the ERCC6 locus spared in two cases. Seven tumors had PTEN gene alterations; two had homozygous DMBT1 deletions, but at least one reflected unmasking of a germline DMBT1 deletion. No mutations were found in ERCC6 exon 2. Chemotherapeutic response occurred in two of the seven tumors with PTEN alterations, but with unexpected short survival times. PTEN gene alterations were not associated with poor therapeutic response in multivariate analysis, but were independently predictive of poor prognosis even after multivariate adjustment for both 10q and 1p loss. In anaplastic oligodendroglioma, therefore, PTEN is a target of 10q loss, and PTEN alterations are associated with poor prognosis, even in chemosensitive cases.

UR - http://www.scopus.com/inward/record.url?scp=0035406063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035406063&partnerID=8YFLogxK

U2 - 10.1016/S0002-9440(10)61702-6

DO - 10.1016/S0002-9440(10)61702-6

M3 - Article

C2 - 11438483

AN - SCOPUS:0035406063

VL - 159

SP - 359

EP - 367

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -